OMIC - Rasio utang marang kapitalisasi buku Singular Genomics Systems Inc

Logo korporat perusahaan Singular Genomics (OMIC)

Singular Genomics Systems (OMIC) generates revenue from robotic DNA sequencing that eliminates manual labor. The company's debt relative to its balance sheet capitalization reflects the dynamics of its credit load, where the 0.44 level serves as a critical benchmark. Expenses are rising due to costly air freight for fragile instruments, while small-batch equipment production hinders the reduction of unit costs.

OMIC - Utang-utang marang aset resik Singular Genomics Systems ing rentang 04.07.2022 - 01.03.2025
Produk dadi Singular Genomics Corp

This indicator reflects the dependence of the balance sheet structure on debt capital relative to equity. A decrease in this metric suggests conservative management, although an excessive avoidance of leverage limits return on assets. Analyzing the ratio of borrowed funds to capitalization allows for an assessment of the issuer's financial stability. For Singular Genomics Systems (OMIC), this is critical due to a technological defeat in the sequencing race. The loss of market position makes the debt load burdensome while seeking new strategies.

Pesaing Singular Genomics Systems

Utang-utang marang kapitalisasi buku TEM (Tempus AI Inc)|qiagen.com - Utang-utang marang kapitalisasi buku|Rasio utang marang kapitalisasi buku IONS (Ionis)|RGEN - Utang-utang marang aset resik|Avidity - Utang-utang marang kapitalisasi buku|CRSP (CRISPR) - Utang-utang marang aset resik|Rasio utang marang kapitalisasi buku GeneDx Holdings Corp. (WGS)|Rasio utang marang nilai buku ultragenyx.com|BEAM: Utang-utang marang kapitalisasi buku|Utang marang aset resik Sarepta Therapeutics SRPT|Utang marang nilai buku TWST (Twist Bio)|10x - Utang-utang marang kapitalisasi buku|NTLA - Rasio utang marang kapitalisasi buku|STOK - Rasio utang marang kapitalisasi buku|BLFS: Utang-utang marang kapitalisasi buku|WVE (Wave Life Sciences Ltd) - Utang-utang marang kapitalisasi buku|MAZE - Rasio utang marang kapitalisasi buku|Rasio utang marang aset resik Sionna Corp (SION)|Prime Medicine, Inc. (PRME) - Utang marang nilai buku|Rasio utang marang aset resik tayshagtx.com (TSHA)|QURE (uniQure) - Utang-utang marang kapitalisasi buku|Utang marang aset resik MeiraGTx Holdings MGTX|RGNX (Regenxbio) - Utang-utang marang kapitalisasi buku|SLDB: Utang-utang marang nilai buku|Rasio utang marang kapitalisasi buku Ocugen, Inc.|PACB (pacb.com) - Rasio utang marang nilai buku|Rasio utang marang kapitalisasi buku BNTC (Benitec Biopharma)|Utang-utang marang nilai buku DSGN|Rasio utang marang kapitalisasi buku RCKT (Rocket Pharmaceuticals Inc)|Utang marang nilai buku 4D Molecular Corp (FDMT)|Utang-utang marang kapitalisasi buku LXEO|Utang-utang marang aset resik Korro Bio Inc. KRRO|EDIT: Utang-utang marang kapitalisasi buku|SLN: Utang marang nilai buku|proqr.com - Rasio utang marang kapitalisasi buku|Utang-utang marang aset resik Codexis|SGMO - Utang marang nilai buku|Rasio utang marang aset resik NAUT|MGX (Metagenomi) - Rasio utang marang kapitalisasi buku|Utang-utang marang aset resik Precision BioSciences Inc. DTIL|GBIO: Utang marang nilai buku|Boundless Bio Inc - Utang-utang marang nilai buku|Rasio utang marang kapitalisasi buku XCUR (Exicure Corp)|Imunon, Inc. (IMNN) - Utang-utang marang aset resik|PHIO - Utang marang nilai buku|Mustang Bio (MBIO) - Utang marang modal buku|Utang-utang marang kapitalisasi buku RNAZ (TransCode Therapeutics Inc.)|Utang-utang marang nilai buku BNGO|Rasio utang marang kapitalisasi buku APDN (Applied DNA Sciences)|Utang marang nilai buku BLUE (bluebirdbio.com)|Rasio utang marang kapitalisasi buku IPA|Omega Therapeutics Inc - Utang-utang marang aset resik|RGLS (Regulus Therapeutics Inc) - Rasio utang marang kapitalisasi buku|SYRS: Utang-utang marang nilai buku|TBIO (Telesis Bio, Inc.) - Rasio utang marang kapitalisasi buku|traconpharma.com (TCON) - Utang marang nilai buku|UBX: Utang-utang marang kapitalisasi buku